Lead PI: Dr Bruce Campbell
Status: Recruiting / Site Selection
No. of Patients Currently Recruited: 53 No. of Patients Required: tbc
Rapid reperfusion is the key to improved ischemic stroke outcomes. Tenecteplase may be safer and more effective than alteplase. The hypothesis of the EXTEND-IA TNK randomised trial is that intravenous tenecteplase will achieve reperfusion prior to cerebral angiography more frequently than intravenous alteplase in patients eligible for clot retrieval.